Richard B. Rothman

21.6k citations

387 papers · 17.5k indexed · 4 hit papers · h-index 70

Cellular and Molecular Neuroscience top 0.02%
Molecular Biology top 0.5%
Toxicology top 0.01%
Pharmacology top 0.2%
Clinical Psychology top 0.5%

Co-authors: Michael H. Baumann Kenner C. Rice John S. Partilla Christina M. Dersch Bryan L. Roth Bruce E. Blough Thomas E. Prisinzano Arthur E. Jacobson
Topics: Receptor Mechanisms and Signaling (230 papers)Neuropeptides and Animal Physiology (185 papers)Neurotransmitter Receptor Influence on Behavior (152 papers)
Cited by: Toxicology Cellular and Molecular Neuroscience Pharmacology
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Circulation
Partner nations: United States Singapore Spain

In The Last Decade

Richard B. Rothman

385 papers receiving 17.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

2000 744 citations Richard B. Rothman, Michael H. Baumann et al. Synapse profile →
A proposal for the classification of sigma binding sites

1992 689 citations Richard B. Rothman et al. profile →
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

2002 621 citations Kenner C. Rice, Richard B. Rothman et al. profile →
Evidence for Possible Involvement of 5-HT_2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

2000 541 citations Richard B. Rothman, Michael H. Baumann et al. profile →

Peers

Countries citing papers authored by Richard B. Rothman

Since Specialization

Citations

This map shows the geographic impact of Richard B. Rothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Rothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Rothman more than expected).

Fields of papers citing papers by Richard B. Rothman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Rothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Rothman. The network helps show where Richard B. Rothman may publish in the future.

Co-authorship network of co-authors of Richard B. Rothman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Rothman. A scholar is included among the top collaborators of Richard B. Rothman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Rothman. Richard B. Rothman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter 2014 ·Drug and Alcohol Dependence ·Maarten E. A. Reith,Bruce E. Blough,Weimin Hong,Kymry T. Jones,Kyle C. Schmitt,Michael H. Baumann,John S. Partilla,Richard B. Rothman,Jonathan L. Katz	108
2	Alpha-ethyltryptamines as dual dopamine–serotonin releasers 2014 ·Bioorganic & Medicinal Chemistry Letters ·Bruce E. Blough,Antonio Landavazo,John S. Partilla,Ann M. Decker,(unknown),Michael H. Baumann,Richard B. Rothman	29
3	Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys. 2014 ·Experimental and Clinical Psychopharmacology ·Matthew L. Banks,(unknown),Bruce E. Blough,Richard B. Rothman,John S. Partilla,Michael H. Baumann,S. Stevens Negus	16
4	Potential drug abuse therapeutics derived from the hallucinogenic natural product salvinorin A 2011 ·MedChemComm ·(unknown),Kimberly M. Lovell,Denise S. Simpson,Victor W. Day,Justin T. Douglas,Peter Bösch,Christina M. Dersch,Richard B. Rothman,Bronwyn M. Kivell,Thomas E. Prisinzano	33
5	In Vitro and In Vivo Assessment of Mu Opioid Receptor Constitutive Activity 2010 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Edward J. Bilsky,Denise Giuvelis,(unknown),Christina M. Dersch,Heng Xu,Richard B. Rothman	6
6	Studies of the Biogenic Amine Transporters. 13. Identification of “Agonist” and “Antagonist” Allosteric Modulators of Amphetamine-Induced Dopamine Release 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Richard B. Rothman,Christina M. Dersch,Subramaniam Ananthan,John S. Partilla	25
7	A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) μ‐opioid agonists on cellular markers related to opioid tolerance and dependence 2006 ·Synapse ·Heng Xu,John S. Partilla,Xiaoying Wang,(unknown),Kevin Tidgewell,Thomas E. Prisinzano,Laura Bohn,Richard B. Rothman	45
8	3,4‐methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein 2004 ·Synapse ·Xiaoying Wang,Michael H. Baumann,Heng Xu,Richard B. Rothman	76
9	Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse 2000 ·Synapse ·Richard B. Rothman,John S. Partilla,Michael H. Baumann,Christina M. Dersch,F. Ivy Carroll,Kenner C. Rice	71
10	Methamphetamine Dependence: Medication Development Efforts Based on the Dual Deficit Model of Stimulant Addiction 2000 ·Annals of the New York Academy of Sciences ·Richard B. Rothman,John S. Partilla,Christina M. Dersch,F. Ivy Carroll,Kenner C. Rice,Michael H. Baumann	16
11	Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice 1999 ·Molecular Brain Research ·Linda S. Brady,Miles Herkenham,Richard B. Rothman,John S. Partilla,(unknown),Anne Zimmer,(unknown)	41
12	Delta opioid binding selectivity of 3-ether analogs of naltrindole 1999 ·Bioorganic & Medicinal Chemistry Letters ·Andrew Coop,(unknown),Lijuan Wang,(unknown),Richard B. Rothman,(unknown),Arthur E. Jacobson,Kenner C. Rice	9
13	Regulation of μ binding sites after chronic administration of antibodies directed against specific anti-opiate peptides 1998 ·Peptides ·(unknown),Simone O. Heyliger,(unknown),John S. Partilla,Hyunwon Yang,(unknown),Jean Lud Cadet,Richard B. Rothman	19
14	Synthesis and biological activity of 3-substituted 3-desoxynaltrindole derivatives 1998 ·Bioorganic & Medicinal Chemistry Letters ·Hitoshi Kubota,Richard B. Rothman,(unknown),(unknown),(unknown),Kenner C. Rice	22
15	Opioid Peptide Receptor Studies. 8. One of the Mouse Brain δNCX Binding Sites is Similar to the Cloned Mouse Opioid δ Receptor: Further Evidence for Heterogeneity of δ Opioid Receptors 1998 ·Peptides ·Heng Xu,(unknown),John S. Partilla,(unknown),(unknown),Dorota Matecka,Kenner C. Rice,Josephine Lai,Frank Porreca,Subramaniam Ananthan,Richard B. Rothman	6
16	Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation 1996 ·Brain Research ·Syed F. Ali,Glenn D. Newport,William Slikker,Richard B. Rothman,Michael H. Baumann	26
17	Lack of evidence for context-dependent cocaine-induced sensitization in humans: Preliminary studies 1994 ·Pharmacology Biochemistry and Behavior ·Richard B. Rothman,David A. Gorelick,Michael H. Baumann,(unknown),Ronald I. Herning,Wallace B. Pickworth,(unknown),(unknown),(unknown),Jack E. Henningfield	43
18	Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence 1991 ·Peptides ·Richard B. Rothman,Joseph B. Long,Victor Bykov,H. Y. Xu,Arthur E. Jacobson,Kenner C. Rice,John W. Holaday	54
19	Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for the .delta.-opioid receptors in vitro 1989 ·Journal of Medicinal Chemistry ·(unknown),Richard B. Rothman,Arthur E. Jacobson,Mariena V. Mattson,Victor Bykov,Richard A. Streaty,Werner A. Klee,Clifford George,Joseph B. Long,Kenner C. Rice	20
20	[3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptors 1987 ·Neuropeptides ·Stafford McLean,(unknown),Ralph A. Lessor,Richard B. Rothman	9

About Richard B. Rothman

Richard B. Rothman is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Molecular Biology, having authored 387 papers that have together received 17.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (230 papers), Neuropeptides and Animal Physiology (185 papers) and Neurotransmitter Receptor Influence on Behavior (152 papers). The work is most often cited by research in Toxicology (2.7k citations), Cellular and Molecular Neuroscience (12.6k citations) and Pharmacology (2.3k citations). Richard B. Rothman has collaborated with scholars based in United States, Singapore and Spain. Frequent co-authors include Michael H. Baumann, Kenner C. Rice, John S. Partilla, Christina M. Dersch, Bryan L. Roth, Bruce E. Blough, Thomas E. Prisinzano, Arthur E. Jacobson, Heng Xu and Miles Herkenham. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact